HEPION PHARMACEUTICALS INC COM
Reported by PNC FINANCIAL SERVICES GROUP INC
Reported 0 shares, down 7,724 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-06-30 | 30230 |
| 2023-09-30 | 14366 |
| 2023-12-31 | 9328 |
| 2024-03-31 | 19619 |
| 2024-06-30 | 7878 |
| 2024-09-30 | 5175 |
| 2024-12-31 | 3630 |
| 2025-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2025 | Reduced | 0 | -7,724 (-100.0%) | 0 | $0 | 2025-05-09 | |
| Q4 2024 | Unchanged | 7,724 | 0 (0.0%) | < 0.01% | $3,630 | 2025-02-07 | |
| Q3 2024 | Unchanged | 7,724 | 0 (0.0%) | < 0.01% | $5,175 | 2024-11-08 | |
| Q2 2024 | Reduced | 7,724 | -155 (-2.0%) | < 0.01% | $7,878 | 2024-08-09 | |
| Q1 2024 | Added | 7,879 | +5,000 (173.7%) | < 0.01% | $19,619 | 2024-05-10 | |
| Q4 2023 | Unchanged | 2,879 | 0 (0.0%) | < 0.01% | $9,328 | 2024-02-09 | |
| Q3 2023 | Unchanged | 2,879 | 0 (0.0%) | < 0.01% | $14,366 | 2023-11-13 | |
| Q2 2023 | New | 2,879 | +2,879 (0.0%) | < 0.01% | $30,230 | 2023-08-11 |
Who else reported the position
21 managers reported HEPION PHARMACEUTICALS INC COM for Q1 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 0 | -50,251 | 0 | $0 | 8 qtrs |
| SIGNATUREFD LLC | Reduced | 0 | -1 | 0 | $0 | 2 qtrs |
| SBI Securities Co Ltd | Reduced | 0 | -125 | 0 | $0 | 2 qtrs |
| BlackRock Inc | Reduced | 0 | -82,954 | 0 | $0 | 3 qtrs |
| UBS Group AG | Reduced | 0 | -14,030 | 0 | $0 | 8 qtrs |
| PNC FINANCIAL SERVICES GROUP INC This report | Reduced | 0 | -7,724 | 0 | $0 | 8 qtrs |
| Anson Funds Management LP | Reduced | 0 | -231,849 | 0 | $0 | 3 qtrs |
| Citigroup Inc | Reduced | 0 | -1 | 0 | $0 | 2 qtrs |
| STATE STREET CORPORATION | Reduced | 0 | -15,676 | 0 | $0 | 8 qtrs |
| CONCOURSE FINANCIAL GROUP SECURITIES INC | Unchanged | 0 | 0 | 0 | $0 | 8 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2025
- Filed
- May 09, 2025
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.